Condensed Consolidated Statements of Stockholders' Equity (unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Balance at Dec. 31, 2022	$ 289,111	$ 40	$ 721,143	$ (402,124)	$ (29,948)
Beginning Balance, shares at Dec. 31, 2022		40,127,522
Stock-based compensation	13,931		13,931
Vesting of restricted stock units and performance-based restricted stock units, shares		250,127
Stock award shares withheld to settle employee tax withholding liability	(1,866)		(1,866)
Stock award shares withheld to settle employee tax withholding liability, shares		(56,062)
Exercise of stock options	1,263		1,263
Exercise of stock options, shares		71,166
Issuance of shares under employee stock purchase plan	2,546		2,546
Issuance of shares under employee stock purchase plan, shares		88,863
Other comprehensive income (loss)	2,426				2,426
Net loss	(14,648)			(14,648)
Balance at Mar. 31, 2023	292,763	$ 40	737,017	(416,772)	(27,522)
Ending Balance, shares at Mar. 31, 2023		40,481,616
Balance at Dec. 31, 2023	302,309	$ 41	771,779	(449,429)	(20,082)
Beginning Balance, shares at Dec. 31, 2023		41,199,583
Stock-based compensation	12,211		12,211
Vesting of restricted stock units and performance-based restricted stock units	1	$ 1
Vesting of restricted stock units and performance-based restricted stock units, shares		301,591
Stock award shares withheld to settle employee tax withholding liability	(2,164)		(2,164)
Stock award shares withheld to settle employee tax withholding liability, shares		(81,668)
Exercise of stock options	$ 53		53
Exercise of stock options, shares	2,000	2,000
Issuance of shares under employee stock purchase plan	$ 1,853		1,853
Issuance of shares under employee stock purchase plan, shares		89,743
Other comprehensive income (loss)	(6,039)				(6,039)
Net loss	(20,068)			(20,068)
Balance at Mar. 31, 2024	$ 288,156	$ 42	$ 783,732	$ (469,497)	$ (26,121)
Ending Balance, shares at Mar. 31, 2024		41,511,249